X4 Pharmaceuticals Inc (XFOR)
1.15
+0.07
(+6.48%)
USD |
NASDAQ |
May 03, 16:00
1.14
-0.01
(-0.87%)
After-Hours: 20:00
X4 Pharmaceuticals 1 Year Total Returns (Daily): -22.30% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -22.30% |
May 02, 2024 | -25.00% |
May 01, 2024 | -29.62% |
April 30, 2024 | -23.81% |
April 29, 2024 | -25.85% |
April 26, 2024 | -22.33% |
April 25, 2024 | -16.30% |
April 24, 2024 | -9.79% |
April 23, 2024 | -15.17% |
April 22, 2024 | -6.21% |
April 19, 2024 | -10.00% |
April 18, 2024 | -11.11% |
April 17, 2024 | 1.27% |
April 16, 2024 | 14.78% |
April 15, 2024 | 8.70% |
April 12, 2024 | 17.54% |
April 11, 2024 | 29.99% |
April 10, 2024 | 40.23% |
April 09, 2024 | 54.00% |
April 08, 2024 | 56.42% |
April 05, 2024 | 64.52% |
April 04, 2024 | 77.11% |
April 03, 2024 | 62.43% |
April 02, 2024 | 58.62% |
April 01, 2024 | 62.07% |
Date | Value |
---|---|
March 28, 2024 | 56.18% |
March 27, 2024 | 77.36% |
March 26, 2024 | 72.64% |
March 25, 2024 | 73.83% |
March 22, 2024 | 70.76% |
March 21, 2024 | 46.30% |
March 20, 2024 | 15.02% |
March 19, 2024 | 15.57% |
March 18, 2024 | 9.92% |
March 15, 2024 | 2.43% |
March 14, 2024 | -8.99% |
March 13, 2024 | -7.50% |
March 12, 2024 | -2.27% |
March 11, 2024 | 3.12% |
March 08, 2024 | -10.17% |
March 07, 2024 | -11.86% |
March 06, 2024 | 1.42% |
March 05, 2024 | -0.61% |
March 04, 2024 | 1.40% |
March 01, 2024 | 6.32% |
February 29, 2024 | 3.48% |
February 28, 2024 | -0.86% |
February 27, 2024 | 10.38% |
February 26, 2024 | 3.27% |
February 23, 2024 | 0.21% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-87.91%
Minimum
Jun 07 2022
117.1%
Maximum
Jun 14 2023
-30.82%
Average
-37.90%
Median
Jul 21 2020
1 Year Total Returns (Daily) Benchmarks
Phio Pharmaceuticals Corp | -80.30% |
Ocular Therapeutix Inc | -0.32% |
Alpine Immune Sciences Inc | 824.2% |
Scholar Rock Holding Corp | 110.6% |
Pyxis Oncology Inc | 49.49% |